Johnson & Johnson Exceeds First-quarter Earnings Projections
Johnson & Johnson (JNJ) exceeded first-quarter earnings projections with revenue of $24.1 billion and adjusted EPS of $2.70. The company raised its full-year sales forecast to $100.8 billion and adjusted EPS guidance to $11.55, driven by strong performance in Darzalex and Tremfya despite a decline in Stelara sales.
Tickers: $JNJ
Topics: Darzalex Earnings Guidance Update Revenue Stelara Stock Performance Tremfya